Saffron is the dried stigmas of the flower of Crocus sativus, a plant of the iris family. It is used as a spice and as a food color. Supplements contain saffron extracts; makers may state their content of crocins or safranal, compounds of saffron. Branded extracts include affron, Safr'Inside and Satiereal.
Terms and sources
- Crocus sativus
- Family Iridaceae. Jackson et al., Frontiers in Nutrition, 2021; Hasheminasab et al., Health Science Reports, 2026.
- food color
- Saffron colors and flavors food and is also used in cosmetics. Bostan et al., Iranian Journal of Basic Medical Sciences, 2017.
- crocins or safranal
- Crocins give saffron its color; safranal gives its smell. Bostan et al., Iranian Journal of Basic Medical Sciences, 2017.
- Branded extracts
- Names as given in the trial reports cited on this page.
Saffron in the body
Saffron is not a nutrient, and the body has no daily requirement for it. Trials of its extracts measure things such as self-rated mood, sleep and stress.
The dried stigmas contain about 150 compounds, and fewer than half of them have been identified. Crocin gives the spice its yellow-orange color, picrocrocin its bitter taste and safranal its smell. Fresh stigmas lack safranal; it forms from picrocrocin as the stigmas are dried and stored.
Terms and sources
- about 150 compounds
- Volatile and non-volatile compounds. Bostan et al., Iranian Journal of Basic Medical Sciences, 2017. Fewer than half identified: Hasheminasab et al., Health Science Reports, 2026.
- Crocin
- A carotenoid pigment. Bostan et al., Iranian Journal of Basic Medical Sciences, 2017. Hasheminasab et al., Health Science Reports, 2026.
- forms from picrocrocin
- An enzyme splits picrocrocin during drying and storage. Tufail et al., Food Science & Nutrition, 2025.
Trial reports of branded extracts state the share of chosen compounds, such as crocins or safranal. Crocetin is a breakdown product of crocin. In one 8-week trial, urine crocetin was 0.46 ng/mg creatinine with saffron extract and 0.05 with a dummy pill.
Terms and sources
- Trial reports of branded extracts
- affron: Lopresti et al., 2022. Safr'Inside: Pouchieu et al., 2023.
- Crocetin
- Jackson et al., Frontiers in Nutrition, 2021.
- 0.46 ng/mg creatinine
- Nanograms of crocetin per milligram of creatinine, a urine measure that allows for how dilute the urine is. Average of weeks 2 to 8; Safr'Inside, 30 mg a day. Jackson et al., Frontiers in Nutrition, 2021.
A review of 102 trials found saffron generally well tolerated at usual amounts over short periods. Side effects were mostly mild and passing; the most common were stomach upsets, such as nausea. Within the common range of 15–100 mg a day, higher amounts did not bring clearly more side effects. The review could not set an amount at which side effects begin. It asks for extra care in older people and in people with mental health conditions. It asks the same for people taking medicines that slow blood clotting, after one case of bleeding. It also lists people who are pregnant or breastfeeding, because safety data for them are limited. For much higher amounts or long use, the review advises medical supervision.
Terms and sources
- 102 trials
- Trials of saffron alone: ground stigma or extracts, in healthy people and in people with various conditions. Hasheminasab et al., Health Science Reports, 2026.
- stomach upsets
- Also changes in appetite and stomach pain. Headache was also reported. Hasheminasab et al., Health Science Reports, 2026.
- one case of bleeding
- A man taking a blood-thinning medicine with a saffron supplement; the bleeding stopped when he stopped both. Hasheminasab et al., Health Science Reports, 2026.
- much higher amounts or long use
- Above the common range of 15–100 mg a day, or for long periods. Hasheminasab et al., Health Science Reports, 2026.
Where saffron comes from
The saffron plant has leaves, a bulb and a flower with stamens, petals and stigmas. The spice comes only from the dried stigmas. Saffron is grown in countries including Iran, Greece, Spain, China and Turkey.
Terms and sources
- bulb
- Studies also call it a corm. Tufail et al., Food Science & Nutrition, 2025.
- petals
- Botanists call them tepals. Hasheminasab et al., Health Science Reports, 2026.
- dried stigmas
- Hasheminasab et al., Health Science Reports, 2026.
- Iran, Greece, Spain, China and Turkey
- Bostan et al., Iranian Journal of Basic Medical Sciences, 2017.
The ISO saffron standard grades the spice by its crocin, picrocrocin and safranal content and by moisture. Petals are the main by-product of saffron processing; they are produced in large amounts and discarded. They contain other compounds, such as kaempferol and anthocyanins. Most labels that name a plant part name the stigma; some name the flower. affron, Safr'Inside and Satiereal are stigma extracts, by their trial reports.
Terms and sources
- ISO saffron standard
- ISO 3632. Locatelli et al., Scientific Reports, 2025.
- main by-product
- Ghasemzadeh Rahbardar and Hosseinzadeh, Naunyn-Schmiedeberg's Archives of Pharmacology, 2023.
- kaempferol and anthocyanins
- Also alkaloids, flavonoids and minerals. Ghasemzadeh Rahbardar and Hosseinzadeh, 2023.
- Most labels that name a plant part
- Our count of US labels: 123 name the stigma, 35 the flower, 4 the bulb.
Published studies of saffron
3 studies in adults without a diagnosis: 1 found no difference, 2 had mixed results.
All 3 are single trials: 1 of affron and 2 of Safr'Inside. Trials that required a sleep or mood score in a clinical range to enter are not shown. Nor are trials whose entry criteria we could not read. Seven trials are left out for these reasons. Reviews that combine saffron trials mostly include people with diagnoses and are not shown either.
Our one-line summary comes first. The original is on PubMed.
Show the 3 studies
Adults with low mood took Safr'Inside or a dummy pill; overall mood scores did not differ, low-mood scores fell more.
Trial · 56 analyzed; at least 63 randomized · 8 weeks · maker-funded
Jackson et al., Frontiers in Nutrition, 2021
Terms and sources
- Adults with low mood
- healthy, aged 18–54, with low mood and stress below a diagnosis; people with a diagnosis were excluded
- Safr'Inside
- saffron stigma extract, 15 mg twice a day
- a dummy pill
- placebo: maltodextrin capsules
- overall mood scores
- Total mood disturbance on a mood questionnaire, the main outcome: no difference. Nervousness questionnaires did not differ either.
- low-mood scores
- The low-mood scale of the same questionnaire fell more with Safr'Inside; statistically significant, at the threshold. Social-relationship scores were higher at week 8. In a lab stress test, one pulse-rhythm measure fell with the dummy pill, not with saffron. Stomach upset: 5 people with saffron, 0 with the dummy pill. Against saffron: one coping score rose less; statistically significant. Relaxation ratings after the stress test changed differently with saffron; statistically significant. Saffron users rated themselves less relaxed at 105 minutes.
- maker-funded
- Activ'Inside, maker of Safr'Inside, paid for the study and provided the capsules; 5 authors work for Activ'Inside.
Study · Free full text · about 36 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Healthy adults with low mood and stress took Safr'Inside, 30 mg a day, or a dummy pill for 8 weeks. People with a diagnosed condition were excluded. The main mood score did not differ between the groups. The low-mood part of the same questionnaire fell more with saffron. This difference was statistically significant. One coping score rose less with saffron. In a lab stress test, one pulse-rhythm measure dropped with the dummy pill but not with saffron. Five people had stomach upset with saffron, none with the dummy pill. 56 people were analyzed. Funding: Activ'Inside, the maker, paid.
Active adults took affron or a dummy pill for 6 weeks; exercise enjoyment, mood and sleep did not differ.
Trial · 62 people · 6 weeks · maker-funded
Lopresti et al., Journal of the International Society of Sports Nutrition, 2022
Terms and sources
- Active adults
- healthy adults aged 18–65 who exercise more than 3 times a week
- affron
- saffron stigma extract, 14 mg twice a day
- a dummy pill
- placebo
- exercise enjoyment
- The main outcome: no difference between groups. In men only, enjoyment and one pulse-rhythm measure rose more with affron; women showed no difference. The authors call the split by sex preliminary.
- sleep
- Sleep time and efficiency from a wrist tracker, and resting pulse: no difference. Blood levels of three brain-related proteins did not differ.
- maker-funded
- Pharmactive, maker of affron, paid for the study. The lead author runs a research company that has received funding from supplement makers.
Study · Free full text · about 35 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers gave 62 healthy adults who exercise regularly affron or a dummy pill for 6 weeks. The affron dose was 14 mg twice a day. Exercise enjoyment, the main outcome, did not differ between the groups. Mood questionnaires did not differ either. Sleep and resting pulse from a wrist tracker showed no difference. Three blood proteins did not differ. In men only, enjoyment and one pulse-rhythm measure rose more with affron. The authors call this split by sex preliminary. Side effects were mild. Funding: Pharmactive, maker of affron, paid for the study.
Men took Safr'Inside or a dummy powder before a stress test; cortisol peaked later, stress ratings did not differ significantly.
Trial · 19 people · one dose · maker-funded
Pouchieu et al., Nutrients, 2023
Terms and sources
- Men
- healthy, aged 18–25; each took all three products, one after the other, 28 days apart
- Safr'Inside
- saffron stigma extract, one 30 mg dose taken under the tongue; it holds 0.06 mg of safranal. A third test used 0.06 mg of synthetic safranal.
- a dummy powder
- placebo: maltodextrin
- cortisol peaked later
- Cortisol, a stress hormone, and cortisone in saliva peaked later than with the dummy powder; statistically significant. Their highest levels and totals did not differ.
- stress ratings
- Across the three products, stress and nervousness ratings differed. Compared one by one with the dummy powder, only synthetic safranal differed; Safr'Inside did not. The abstract reports both as lower.
- maker-funded
- Activ'Inside, maker of Safr'Inside, paid for the study with money from a French public investment program. Three authors work for Activ'Inside, which provided the products.
Study · Free full text · about 25 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
Researchers tested a single 30 mg dose of Safr'Inside in 19 healthy men aged 18 to 25. Each man took the extract, synthetic safranal and a dummy powder, 28 days apart. Each dose came before a lab stress test. With the extract, cortisol in saliva peaked later than with the dummy powder. This difference was statistically significant. Peak cortisol levels did not differ. Compared one by one with the dummy powder, stress ratings differed only for synthetic safranal. Women were not studied. Funding: Activ'Inside, the maker, with a French public program; three authors work for it.
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.